期刊文献+

胰泰复方对慢性胰腺炎胰腺纤维化大鼠NF-KB、IL-1影响的实验研究 被引量:11

Experimental Study on Influence of Yitai Prescription on NF-KB and IL-1 of Rats with Chronic Pancreatitis Pancreatic Fibrosis
原文传递
导出
摘要 目的:观察中药胰泰复方对慢性胰腺炎胰腺纤维化大鼠胰腺组织中NF-κB、IL-1的影响。方法:给予13.3%L-精氨酸在大鼠左下腹腔注射,制备慢性胰腺炎模型;10 d后给予灌胃治,两个月后取材,观察慢性胰腺炎胰腺纤维化大鼠胰腺组织中NF-κB P50、IL-1的表达。结果:模型组NF-κB P50及IL-1的阳性表达明显高于中药对照组及中药治疗组,中药治疗组NF-κB P50及IL-1的阳性表达明显低于中药对照组(P<0.01),有统计学意义。结论:胰泰复方能够有效抑制NF-κB及IL-1的阳性表达,对慢性胰腺炎胰腺纤维化具有明显的治疗作用。 Objective:To observe the effect of traditional Chinese medicine of Yitai prescription on NF - K B and IL - lfor chronic pancreatitis pancreatic fibrosis rats. Methods : 13.3% L - arginine was injected into left lower abdominal cavity of rats to establish chronic pancreatitis;after 10 days rats were treated intragastrically, two months after the operation, observation of NF - K B PSO and IL - 1 expressions of chronic pancreatitis pancreatic fibrosis rats. Result : In the model group, NF - κB PS0 and IL - 1 expressions were significantly higher than that of Chinese medicine control group and Chinese traditional medicine treatment group, NF - κB PS0 and IL - 1 expressions in treatment group were significantly lower than that of control group ( P 〈 0.01 ), traditional Chinese medicine treatment group has statistical significance. Conclusion : Yital prescription can effectively inhibit NF - κB and expression of IL - 1, on pancreas fibrosis of chronic pancreatitis with therapeutic effect.
出处 《中华中医药学刊》 CAS 2013年第2期244-246,I0002,共4页 Chinese Archives of Traditional Chinese Medicine
基金 教育部"春晖计划"合作科研资助项目(404S809)
关键词 胰泰复方 慢性胰腺炎 大鼠 NF—κB- IL-1 实验研究 Yitai prescription chronic pancreatitis rat NF - κ B IL - 1 experimental study
  • 相关文献

参考文献8

二级参考文献46

  • 1杨丽丽,戢新平,刘志,刘刚,关福兰.高碳酸血症对急性肺损伤时核因子-κB和TNF-α的影响[J].中国应用生理学杂志,2004,20(4):396-400. 被引量:3
  • 2许小波.脂质过氧化与癌肿形成[J].生命的化学,1995,15(6):42-43. 被引量:19
  • 3雷德虎.急性胰腺炎内科治疗新进展[J].衡阳医学院学报,1996,24(3):251-254. 被引量:2
  • 4Lord PCW,Wilomth LMG,Mizel SB,et al.Expression of interleukin-1 alpha and beta genes by human blood polymorphonuclear leukocytes[J].JClin.Invest.1991,87:1312-1321.
  • 5Yonemura Y,Ku H,Hirayama F,et al.Interkeukin 3 or interleukin 1 abrogates the reconstituting ability of hematopoietic stem cells[J].Proc Natl Acad Sci USA,1996,93:4040 -4044.
  • 6Zsebo KM,Yuschenkoff VN,Schiffer S,et al.Vascular endothelial cells and granulopoiesis:interleukin-1 stimulates release of G-CSF and GM-CSF[J].Blood,1988,71:99-103.
  • 7Wright DE,Bowman EP,Wagers AJ,et al.Hematopoietic stem cells are uniquely selective in their migratory response to chemokines[J].J Exp Med,2002,195:1145 -1154.
  • 8Schaafsma MR,Fibbe WE,Vander HD,et al.Increased numbers of circulating haematopoietic progenitor cells after treatment with highdose interleukin22 cancer patients[J].Br J Haematol,1990,76 (2):180-185.
  • 9Yee CC,Gabriela R,Leah FS,et al.Interleukin-2 and granulocyte-macrophage-colony-stimulating factor immunomodulation with high-dose chemotherapy and autologous hematopoietic stem cell transplantation for patients with metastatic breast cancer[J].J Hematol 2009,90:627-634 DOI 10.1007/sl2185-009-0439-6.
  • 10Lonial S,Hicks M,Rosenthal H,Langston A,Redei I and Torre C,et al.A randomized trial comparing the combination of granulocyte-macrophage colony-stimulating factor plus granulocyte colony-stimulating factor versus granulocyte colony-stimulating factor for mobilization of dendritic cell subsets in hematopoietic progenitor cell products,Biol Blood Harrow Transplant 2004 (10),848-857.

共引文献39

同被引文献145

引证文献11

二级引证文献29

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部